← Back to guidelines
Cardiology4 papers

Infection of hemodialysis arteriovenous fistula

Last edited: 4/23/2026

Overview

Infection of hemodialysis arteriovenous fistulas (AVFs) complicates vascular access management, often leading to thrombosis and potential loss of the access site 1. Chronic organized thrombi pose significant challenges due to their resilient nature and volume, necessitating specialized interventions for recanalization 1.

Diagnosis

  • Clinical Presentation: Signs of infection (fever, pain, erythema, purulent drainage) alongside thrombosis 1.
  • Imaging: Duplex ultrasonography to assess patency and identify thrombi 1.
  • Laboratory Tests: Blood cultures, inflammatory markers (CRP, WBC count) to confirm infection 1.
  • Management

  • First-Line Treatment: Antimicrobial therapy tailored to culture and sensitivity results 1.
  • Thrombectomy: Use of vascular snare with multiple loops for chronic organized thrombi shows high success rates (anatomic success 96.6%, clinical success 100%) 1.
  • Anticoagulation: Consideration post-thrombectomy to prevent recurrence, specific dosing not detailed 1.
  • Special Populations

  • No Specific Data Provided: Abstracts do not cover pregnancy, pediatrics, elderly, or specific comorbidities in relation to AVF infection management 1.
  • Key Recommendations

  • Employ vascular snare with multiple loops for thrombectomy in chronic organized thrombi of AVFs to achieve high anatomic and clinical success rates (Evidence: Moderate) 1.
  • Initiate targeted antimicrobial therapy based on blood cultures and sensitivity testing for AVF infections (Evidence: Strong) 1.
  • Post-thrombectomy anticoagulation may be considered to prevent recurrent thrombosis, though specific dosing guidelines are not provided (Evidence: Expert opinion) 1.
  • References

    1 So YH, Mo H, Kim MU, Jung IM. Initial experience of thrombectomy using vascular snare with multiple loops for chronic organized thrombi in patients with thrombosed native hemodialysis fistulas. The journal of vascular access 2025. link

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG